Phreesia Price to Free Cash Flow Ratio 2019-2025 | PHR
Historical price to free cash flow ratio values for Phreesia (PHR) since 2019.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Phreesia Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-18 | 25.66 | 67.63 | |
| 2025-04-30 | 24.96 | $0.38 | 65.79 |
| 2025-01-31 | 28.46 | $0.14 | 197.64 |
| 2024-10-31 | 18.29 | $-0.23 | 0.00 |
| 2024-07-31 | 24.95 | $-0.45 | 0.00 |
| 2024-04-30 | 20.74 | $-0.79 | 0.00 |
| 2024-01-31 | 25.48 | $-1.05 | 0.00 |
| 2023-10-31 | 13.66 | $-1.28 | 0.00 |
| 2023-07-31 | 31.72 | $-1.60 | 0.00 |
| 2023-04-30 | 31.64 | $-1.81 | 0.00 |
| 2023-01-31 | 37.49 | $-2.22 | 0.00 |
| 2022-10-31 | 27.32 | $-2.70 | 0.00 |
| 2022-07-31 | 23.49 | $-2.94 | 0.00 |
| 2022-04-30 | 22.88 | $-2.63 | 0.00 |
| 2022-01-31 | 31.19 | $-2.12 | 0.00 |
| 2021-10-31 | 70.54 | $-1.28 | 0.00 |
| 2021-07-31 | 68.35 | $-0.63 | 0.00 |
| 2021-04-30 | 51.75 | $-0.64 | 0.00 |
| 2021-01-31 | 65.29 | $-0.40 | 0.00 |
| 2020-10-31 | 36.97 | $-0.62 | 0.00 |
| 2020-07-31 | 30.06 | $-0.33 | 0.00 |
| 2020-04-30 | 25.39 | $-0.60 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.527B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.989B | 58.51 |
| Hims & Hers Health (HIMS) | United States | $13.669B | 142.02 |
| Tempus AI (TEM) | United States | $11.962B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.646B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.825B | 59.77 |
| Hinge Health (HNGE) | United States | $3.100B | 0.00 |
| Privia Health (PRVA) | United States | $2.659B | 181.75 |
| Enovis (ENOV) | United States | $1.751B | 9.76 |
| Schrodinger (SDGR) | United States | $1.545B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Azenta (AZTA) | United States | $1.371B | 63.70 |
| 10x Genomics (TXG) | United States | $1.338B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Claritev (CTEV) | United States | $0.663B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 766.67 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.139B | 0.00 |
| Pulmonx (LUNG) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |